Home/Filings/4/0001214659-24-017482
4//SEC Filing

Laponis Adam 4

Accession 0001214659-24-017482

CIK 0001581280other

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 4:05 PM ET

Size

5.4 KB

Accession

0001214659-24-017482

Insider Transaction Report

Form 4
Period: 2024-10-09
Laponis Adam
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-10-09$41.81/sh856$35,79173,397 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
  • [F2]Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

Twist Bioscience Corp

CIK 0001581280

Entity typeother

Related Parties

1
  • filerCIK 0001827198

Filing Metadata

Form type
4
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:05 PM ET
Size
5.4 KB